关注
Karla Hernandez-Villafuerte
Karla Hernandez-Villafuerte
Senior Researcher - Health Economics WifOR Institute
在 wifor.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
How much does it cost to research and develop a new drug? A systematic review and assessment
M Schlander, K Hernandez-Villafuerte, CY Cheng, J Mestre-Ferrandiz, ...
Pharmacoeconomics 39, 1243-1269, 2021
1892021
Mapping priority setting in health in 17 countries across Asia, Latin America, and sub-Saharan Africa
R Li, K Hernandez-Villafuerte, A Towse, I Vlad, K Chalkidou
Health Systems & Reform 2 (1), 71-83, 2016
532016
Economic evaluation of meningococcal vaccines: considerations for the future
H Christensen, H Al-Janabi, P Levy, MJ Postma, DE Bloom, P Landa, ...
The European Journal of Health Economics 21, 297-309, 2020
372020
Bibliometric trends of health economic evaluation in Sub-Saharan Africa
K Hernandez-Villafuerte, R Li, KJ Hofman
Globalization and Health 12, 1-15, 2016
322016
Cost‐effectiveness of risk‐based breast cancer screening: a systematic review
SA Khan, KV Hernandez‐Villafuerte, MT Muchadeyi, M Schlander
International journal of cancer 149 (4), 790-810, 2021
232021
Economies of scale and scope in publicly funded biomedical and health research: evidence from the literature
K Hernandez-Villafuerte, J Sussex, E Robin, S Guthrie, S Wooding
Health Research Policy and Systems 15, 1-17, 2017
232017
Challenges and methodologies in using progression free survival as a surrogate for overall survival in oncology
K Hernandez-Villafuerte, A Fischer, N Latimer
International Journal of Technology Assessment in Health Care 34 (3), 300-316, 2018
172018
Kosten der Onkologie in Deutschland
M Schlander, K Hernandez-Villafuerte, C Thielscher
Forum 33 (5), 330-337, 2018
142018
The value of international volunteers experience to the NHS
B Zamora, M Gurupira, M Rodes Sanchez, Y Feng, ...
Globalization and Health 15, 1-12, 2019
122019
Government and charity funding of cancer research: public preferences and choices
KK Shah, J Sussex, K Hernandez-Villafuerte
Health research policy and systems 13, 1-14, 2015
122015
Do NICE decisions affect decisions in other countries?
K Hernández-Villafuerte, M Garau, N Devlin
Value in Health 17 (7), A418, 2014
102014
The relationship between spatial price transmission and geographical distance: the case of Brazil
KV Hernandez-Villafuerte
102010
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany
D Hernandez, C Cheng, K Hernandez-Villafuerte, M Schlander
Oncology Research 30 (4), 173, 2022
92022
Issues surrounding the estimation of the opportunity cost of adopting a new health care technology: areas for further research
K Hernandez-Villafuerte, B Zamora, A Towse
London: Office of Health Economics, 2018
82018
International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa
K Hernandez-Villafuerte, R Li, A Towse, K Chalkidou
Occasional Papers, 2015
82015
Exploring the Interdependencies of Research Funders in the UK
K Shah, J Sussex, K Hernandez-Villafuerte, M Garau, D Rotolo, ...
Available at SSRN 2644302, 2014
82014
Improving efficiency and resource allocation in future cancer care
A Cole, A Lundqvist, P Lorgelly, H Norrlid, S Karlsberg Schaffer, F Lewis, ...
Consulting Reports, 2016
72016
The expanding value footprint of oncology treatments
JC Rejón-Parrilla, K Hernández-Villafuerte, K Shah, J Mestre-Ferrandiz, ...
Value in Health 17 (7), A654, 2014
72014
The relationship between spatial integration and geographical distance in Brazil
K Hernandez-Villafuerte
Annual Meeting of the European Association of Agricultural Economics (EAAE …, 2011
72011
Economic burden of pancreatic cancer in Europe: a literature review
D Hernandez, F Wagner, K Hernandez-Villafuerte, M Schlander
Journal of Gastrointestinal Cancer 54 (2), 391-407, 2023
62023
系统目前无法执行此操作,请稍后再试。
文章 1–20